0
Catégories
Documents disponibles dans cette catégorie (217)
Ajouter le résultat dans votre panier Affiner la rechercheDepression and smoking in the U.S. household population aged 20 and over, 2005-2008 / Laura A. Pratt (2010)
Titre : Depression and smoking in the U.S. household population aged 20 and over, 2005-2008 Type de document : texte imprimé Auteurs : Laura A. Pratt, Auteur ; Debra J. Brody, Auteur Editeur : Centers for Disease Control and Prevention (CDC) Année de publication : 2010 Collection : NCHS Data Brief, ISSN 1941-4927 num. 34 Importance : 7 p. Langues : Français (fre) Catégories : [DIVERS] personne:par âge:adulte
[TABAC] étude
[TABAC] tabagisme:effet du tabac:effet psychiatrique:dépression
[TABAC] tabagisme:tabagisme actifIndex. décimale : TA 3.2.2.6 Effets métaboliques et biologiques En ligne : https://www.cdc.gov/nchs/data/databriefs/db34.pdf Format de la ressource électronique : Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8024 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates? / Véronique Godding (2004)
Titre : Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates? Type de document : document électronique Auteurs : Véronique Godding, Auteur ; Chrisitine Bonnier, Auteur ; Leon Fiasse, Auteur ; Marianne Michel, Auteur ; Étienne Longueville, Auteur ; Patrick Lebecque, Auteur ; Annie Robert, Auteur ; Laurence Galanti, Auteur Editeur : Springer Année de publication : 2004 Collection : Pediatric Research, ISSN 1530-0447 num. 55 Importance : p.645–651 Langues : Anglais (eng) Catégories : [DIVERS] personne:famille:nourrisson
[DIVERS] personne:par sexe:femme:femme enceinte
[TABAC] chimie du tabac:constituant:alcaloïde:nicotine
[TABAC] étude
[TABAC] tabagisme:aspect psychologique:comportement:addiction
[TABAC] tabagisme:risque:facteur associé:grossesse:foetus
[TABAC] tabagisme:tabagisme actif:tabagisme parental
[TABAC] tabagisme:tabagisme passifIndex. décimale : TA 3.2.2.7 Grossesse et fœtus Résumé : Maternal drug use during pregnancy is associated with fetal passive addiction and neonatal withdrawal syndrome. Cigarette smoking—highly prevalent during pregnancy—is associated with addiction and withdrawal syndrome in adults. We conducted a prospective, two-group parallel study on 17 consecutive newborns of heavy-smoking mothers and 16 newborns of nonsmoking, unexposed mothers (controls). Neurologic examinations were repeated at days 1, 2, and 5. Finnegan withdrawal score was assessed every 3 h during their first 4 d. Newborns of smoking mothers had significant levels of cotinine in the cord blood (85.8 ± 3.4 ng/mL), whereas none of the controls had detectable levels. Similar findings were observed with urinary cotinine concentrations in the newborns (483.1 ± 2.5 μg/g creatinine versus 43.6 ± 1.5 μg/g creatinine; p = 0.0001). Neurologic scores were significantly lower in newborns of smokers than in control infants at days 1 (22.3 ± 2.3 versus 26.5 ± 1.1; p = 0.0001), 2 (22.4 ± 3.3 versus 26.3 ± 1.6; p = 0.0002), and 5 (24.3 ± 2.1 versus 26.5 ± 1.5; p = 0.002). Neurologic scores improved significantly from day 1 to 5 in newborns of smokers (p = 0.05), reaching values closer to control infants. Withdrawal scores were higher in newborns of smokers than in control infants at days 1 (4.5 ± 1.1 versus 3.2 ± 1.4; p = 0.05), 2 (4.7 ± 1.7 versus 3.1 ± 1.1; p = 0.002), and 4 (4.7 ± 2.1 versus 2.9 ± 1.4; p = 0.007). Significant correlations were observed between markers of nicotine exposure and neurologic-and withdrawal scores. We conclude that withdrawal symptoms occur in newborns exposed to heavy maternal smoking during pregnancy. En ligne : https://doi.org/10.1203/01.PDR.0000112099.88740.4E Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10112 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : A double-blind study evaluating the long-term safety of varenicline for smoking cessation Type de document : texte imprimé Auteurs : Kathryn Williams, Auteur ; Karen Reeves, Auteur ; Clare B. Billing, Auteur Année de publication : 2007 Importance : p. 793-801 Présentation : ill., tab. Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varéniclineIndex. décimale : TA 6.2.3.1.4 Autres substituts nicotiniques Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7934 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005475 TA 6.2.3.1.4 WIL D Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : L’e-cigarette et sa panoplie d’arômes, un danger ? Type de document : document électronique Auteurs : Robin Gille, Auteur Editeur : Roularta Année de publication : 2023-02-18 Collection : Le Vif / L'Express Importance : 3 p. Langues : Français (fre) Catégories : [DIVERS] géographie:Europe:Europe occidentale:Belgique
[DIVERS] géographie:Europe:Europe occidentale:France
[TABAC] chimie du tabac:constituant:additif:agent de saveur
[TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] économie du tabac:industrie:cigarettier
[TABAC] étude
[TABAC] sevrage tabagiqueIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : La cigarette électronique fait de plus en plus d’adeptes, avec son lot de goûts en tout genre. Un produit qui attire notamment les jeunes. Faut-il se méfier de ce produit et comment le réguler ? Éléments de réponse avec Suzanne Gabriels, experte prévention tabac à la Fondation contre le Cancer Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9832 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : E-cigarette use among high school students—a cross‑sectional study of associated risk factors for the use of flavour‑only and nicotine vapes Type de document : document électronique Auteurs : Janni Leung, Auteur ; Calvert Tisdale, Auteur ; Jisu Choi, Auteur Editeur : Springer Année de publication : 2023 Collection : International Journal of Mental Health and Addiction Importance : 15 p. Présentation : tab. Langues : Anglais (eng) Catégories : [TABAC] CANDIDATS:e-cigarette
[TABAC] chimie du tabac:constituant:additif:agent de saveur
[TABAC] chimie du tabac:constituant:alcaloïde:nicotine
[TABAC] étude
[TABAC] tabagisme:risque:facteur associé
[TABAC] tabagisme:tabagisme actif:tabagisme adolescentMots-clés : e-liquide Index. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : The aim of this study is to examine e-cigarette use among high school students and the associated risk factors for the use of flavour-only or nicotine vapes. Grade 12 students (N = 855) of 2020 from nine Australian schools completed a cross-sectional self-report survey. Correlates examined included age, gender, Aboriginal or Torres Strait Islander, parental and family characteristics, truancy, mental health (depression and anxiety), alcohol use and cigarette smoking. Overall, 74% reported that they had never used an e-cigarette or vaped, 12.5% had for flavour-only, and 13.5% had for nicotine vapes. Multinomial adjusted logistic regressions showed that males and teens reporting frequent alcohol or cigarette use had higher odds of vaping. In adolescents who had used an e-cigarette, half had used a nicotine vape. Those who engaged in risky drinking and smoked cigarettes were most likely to also use e-cigarettes, implying that this may be a high-risk group. En ligne : https://doi.org/10.1007/s11469-023-01099-7 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10266 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : E-cigarettes associated with depressed smoking cessation : cross-sectional study of 28 european union countries Type de document : document électronique Auteurs : Margarete C. Kulik, Auteur ; Nadra E. Lisha, Auteur ; Stanton A. Glantz, Auteur Editeur : Paris [France] : Elsevier Année de publication : 2018 Collection : American Journal of Preventive Medicine num. 54-4 Importance : p. 603-609 Présentation : tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe
[DIVERS] géographie:Europe:Europe occidentale:Royaume-Uni
[TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] étude
[TABAC] sevrage tabagique
[TABAC] tabagisme:tabagisme actif:fumeurMots-clés : ex fumeur Index. décimale : TA 6.2.3.2 Autres produits Résumé : Introduction:
Electronic cigarettes (e-cigarettes) are often promoted to assist with cigarette smoking cessation. In 2016–2017, the relationship between e-cigarette use and having stopped smoking among ever (current and former) smokers was assessed in the European Union and Great Britain by itself.
Methods:
Cross-sectional logistic regression of the association between being a former smoker and e-cigarette use was applied to the 2014 Eurobarometer survey of 28 European Union countries controlling for demographics.
Results:
Among all ever smokers, any regular ever use of nicotine e-cigarettes was associated with
lower odds of being a former smoker (unadjusted OR¼0.34, 95% CI¼0.26, 0.43, AOR¼0.43, 95% CI¼0.32, 0.58) compared with smokers who had never used e-cigarettes. In unadjusted models, daily use (OR¼0.42, 95% CI¼0.31, 0.56); occasional use (OR¼0.25, 95% CI¼0.18, 0.35); and experimentation (OR¼0.24, 95% CI¼0.19, 0.30) of nicotine e-cigarettes were associated with lower odds of being a former smoker compared with having never used nicotine-containing e-cigarettes. Comparable results were found in adjusted models. Results were similar in Great Britain alone. Among current smokers, daily cigarette consumption was 15.6 cigarettes/day (95% CI¼14.5, 16.7) among those who also used e-cigarettes versus 14.4 cigarettes/day (95% CI¼13.4, 15.4) for those who did not use them (po0.05).
Conclusions:
These results that e-cigarettes are associated with inhibiting rather than assisting in smoking cessation. On the population level, the net effect of the entry of e-cigarettes into the European Union (and Great Britain) is associated with depressed smoking cessation of conventional cigarettes.
En ligne : https://doi.org/10.1016/j.amepre.2017.12.017 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9740 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : L'e-tabac, bien ou pas bien ? Type de document : texte imprimé Auteurs : Alice Kriescher, Auteur Editeur : Dison [Belgique] : Belgomedia SA Année de publication : 22/02/2018 Collection : Télépro Magazine Importance : p.103 Langues : Français (fre) Catégories : [TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] étudeIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : Depuis l'apparition de l'e-cigarette, les études scientifiques concernant sa nocivité ne cessent d'affluer et sont parfois contradictoires. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8676 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 006788 TA 1.1.1 KRI E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effect of low-dose thephylline plus beclometasone on lung function in smokers with asthma : a pilot stydy Type de document : texte imprimé Auteurs : M. Spears, Auteur ; I. Donnelly, Auteur ; M. Brannigan, Auteur ; K. Ito, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2009 Collection : European Respiratory Journal num. 33 suppl. Importance : p. 1010-1017 Présentation : tab., graph. Langues : Anglais (eng) Catégories : [PROMOSAN] asthme:traitement de l'asthme
[TABAC] étude
[TABAC] tabagisme:pathologie:pathologie respiratoire:asthmeIndex. décimale : TA 3.2.2.4 Pathologies respiratoires (sauf 3.2.2.1, 3.2.2.2, 3.2.2.3) Résumé : Smoking is common in asthma and is associated with worse asthma control and a reduced therapeutic response to corticosteroids. The present authors hypothesised that treating smokers with asthma with low-dose theophylline added to inhaled corticosteroids would enhance steroid sensitivity and thereby improve lung function and symptoms. In a double-blind, parallel group exploratory trial, 68 asthmatic smokers were randomised to one of three treatments for 4 weeks: inhaled beclometasone (200 microg day(-1)), theophylline (400 mg day(-1)) or both treatments combined. Outcome measures included change in lung function and Asthma Control Questionnaire (ACQ) scores. At 4 weeks, theophylline added to inhaled beclometasone produced an improvement in peak expiratory flow (39.9 L min(-1), 95% confidence intervals (CI) 10.9-68.8) and ACQ score (-0.47, 95% CI -0.91- -0.04) and a borderline improvement in pre-bronchodilator forced expiratory volume in one second (mean difference 165 mL, 95% CI -13-342) relative to inhaled corticosteroid alone. Theophylline alone improved the ACQ score (-0.55, 95% CI -0.99- -0.11), but not lung function. In the present pilot study, the combination of low-dose theophylline and inhaled beclometasone produced improvements in both lung function and symptoms in a group of smokers with asthma. Larger trials are required to extend and confirm these findings. En ligne : https://erj.ersjournals.com/content/33/5/1010 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8065 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effect of maintenance therapy withvarenicline on smoking cessation : a randomized controlled trial Type de document : texte imprimé Auteurs : Serena Tonstad, Auteur ; Philip Tonnesen, Auteur ; Peter Hajek, Auteur Editeur : American Medical Association (AMA) Année de publication : 01/06/2006 Collection : JAMA : Journal of the American Medical Association num. 296 (1) Importance : p.64-71 Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] étude:recherche:recherche clinique:essai clinique randomisé
[TABAC] sevrage tabagique
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varéniclineIndex. décimale : TA 6.2.3.1.4 Autres substituts nicotiniques Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2590 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 001434 TA 6.2.3.1.4 TON E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effect of Pictorial Cigarette PackWarnings on Changes in Smoking Behavior : A Randomized Clinical Trial Type de document : document électronique Auteurs : Noël, T. Brewer, Auteur ; Marissa, G. Hall, Auteur ; Seth, M. Noar, Auteur Editeur : American Medical Association (AMA) Année de publication : 2016 Collection : JAMA Internal Medicine num. 176:7 Importance : 8 p. Présentation : ill., tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Amérique:Amérique du Nord:Etats-Unis
[TABAC] économie du tabac:fabrication du tabac:étiquetage:avertissement combiné
[TABAC] économie du tabac:fabrication du tabac:étiquetage:avertissement sanitaire
[TABAC] étude
[TABAC] tabagisme:aspect psychologique:image du fumeurRésumé : IMPORTANCE
Pictorial warnings on cigarette packs draw attention and increase quit intentions, but their effect on smoking behavior remains uncertain.
OBJECTIVE
To assess the effect of adding pictorial warnings to the front and back of cigarette packs.
DESIGN, SETTING, AND PARTICIPANTS
This 4-week between-participant randomized clinical trial was carried out in California and North Carolina.We recruited a convenience sample of adult cigarette smokers from the general population beginning September 2014 through August 2015. Of 2149 smokers who enrolled, 88%completed the trial. No participants withdrew owing to adverse events.
INTERVENTIONS
We randomly assigned participants to receive on their cigarette packs for 4 weeks either text-only warnings (one of the Surgeon General’s warnings currently in use in the United States on the side of the cigarette packs) or pictorial warnings (one of the Family Smoking Prevention and Tobacco Control Act’s required text warnings and pictures that showed harms of smoking on the top half of the front and back of the cigarette packs).
MAIN OUTCOMES AND MEASURES
The primary trial outcomewas attempting to quit smoking during the study.We hypothesized that smokers randomized to receive pictorial warnings would be more likely to report a quit attempt during the study than smokers randomized to
receive a text-only Surgeon General’s warning.
RESULTS
Of the 2149 participants who began the trial (1039 men, 1060 women, and 34 transgender people; mean [SD] age, 39.7 [13.4] years for text-only warning, 39.8 [13.7] for pictorial warnings), 1901 completed it. In intent-to-treat analyses (n = 2149), smokers whose packs had pictorial warnings were more likely than those whose packs had text-only warnings to attempt to quit smoking during the 4-week trial (40% vs 34%; odds ratio [OR], 1.29; 95% CI, 1.09-1.54). The findings did not differ across any demographic groups. Having quit smoking for at least the 7 days prior to the end of the trial was more common among smokers who received pictorial than those who received text-only warnings (5.7%vs 3.8%; OR, 1.53; 95%CI, 1.02-2.29). Pictorial warnings also increased forgoing a cigarette, intentions to quit
smoking, negative emotional reactions, thinking about the harms of smoking, and conversations about quitting.
CONCLUSIONS AND RELEVANCE
Pictorialwarnings effectively increased intentions to quit, forgoing cigarettes, quit attempts, and successfully quitting smoking over 4 weeks. Our trial
findings suggest that implementing pictorial warnings on cigarette packs in the United States would discourage smoking.
En ligne : https://doi.org/10.1001/jamainternmed.2016.2621 Format de la ressource électronique : Page de l'éditeur Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9574 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effect of smoking cessation counseling on recovery from alcoholism : findings from a randomized community intervention trial Type de document : texte imprimé Auteurs : J.K. Bobo, Auteur ; H.E. Mcllvain, Auteur ; H.A. Lando, Auteur ; R.D. Walker, Auteur ; A. Leed-Kelly, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 1998 Collection : Addiction num. 93 (6) Importance : p. 877-887 Note générale : biblio. Catégories : [TABAC] étude
[TABAC] étude:recherche:recherche clinique:essai clinique randomisé
[TABAC] sevrage tabagique
[TABAC] tabagisme
[TABAC] tabagisme:risque:facteur associé:alcoolIndex. décimale : TA 0.1.1 Congrès, conférence et colloque Résumé : L'article évoque les effets du sevrage tabagique sur le sevrage d'alcool, en étudiant un groupe de participant. Ce n'est pas concluant. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1409 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 000485 TA 0.1.1 SMO S Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effect of the italian smoking ban on population rates of acute coronary events Type de document : texte imprimé Auteurs : Giulia Cesaroni, Auteur ; Francesco Forastiere, Auteur ; Nera Agabiti, Auteur ; Pasquale Valente, Auteur Editeur : Lippincott Williams & Wilkins Année de publication : 2010 Collection : Circulation, ISSN 0009-7322 num. 117 Importance : p.1183-1188 Présentation : tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe méridionale:Italie
[TABAC] étude
[TABAC] législation:milieu réglementé:lieu public
[TABAC] tabagisme:pathologie:pathologie cardio-vasculaire
[TABAC] tabagisme:tabagisme passifIndex. décimale : TA 9.3.6.1 Lieux publics Résumé : ackground— Several countries in the world have not yet prohibited smoking in public places. Few studies have been conducted on the effects of smoking bans on cardiac health. We evaluated changes in the frequency of acute coronary events in Rome, Italy, after the introduction of legislation that banned smoking in all indoor public places in January 2005.
Methods and Results— We analyzed acute coronary events (out-of-hospital deaths and hospital admissions) between 2000 and 2005 in city residents 35 to 84 years of age. We computed annual standardized rates and estimated rate ratios by comparing the data from prelegislation (2000–2004) and postlegislation (2005) periods. We took into account several time-related potential confounders, including particulate matter (PM10) air pollution, temperature, influenza epidemics, time trends, and total hospitalization rates. The reduction in acute coronary events was statistically significant in 35- to 64-year-olds (11.2%, 95% CI 6.9% to 15.3%) and in 65- to 74-year-olds (7.9%, 95% CI 3.4% to 12.2%) after the smoking ban. No evidence was found of an effect among the very elderly. The reduction tended to be greater in men and among lower socioeconomic groups.
Conclusions— We found a statistically significant reduction in acute coronary events in the adult population after the smoking ban. The size of the effect was consistent with the pollution reduction observed in indoor public places and with the known health effects of passive smoking. The results affirm that public interventions that prohibit smoking can have enormous public health implicationsPermalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8088 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005637 TA 9.3.6.1 CES E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effect of tobacco smoking on survival of men and woman by social position : a 28 year cohort study Type de document : texte imprimé Auteurs : Laurence Gruer, Auteur ; Carole, L. Hart, Auteur ; David S. Gordon, Auteur ; Graham C. Watt, Auteur Editeur : BMJ Publishing Group Année de publication : 2009 Collection : British Medical Journal num. 336 Importance : 8 p. Présentation : tab., graph. Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] étude:statistique:morbidité
[TABAC] étude:statistique:mortalité
[TABAC] sevrage tabagique:méthode de sevrage:méthode collective:approche socialeIndex. décimale : TA 3.2 Effets du tabagisme actif Résumé : Objective To assess the impact of tobacco smoking on the survival of men and women in different social positions.
Design A cohort observational study.
Setting Renfrew and Paisley, two towns in west central Scotland.
Participants 8353 women and 7049 men aged 45-64 years recruited in 1972-6 (almost 80% of the population in this age group). The cohort was divided into 24 groups by sex (male, female), smoking status (current, former, or never smokers), and social class (classes I + II, III non-manual, III manual, and IV + V) or deprivation category of place of residence.
Main outcome measure Relative mortality (adjusted for age and other risk factors) in the different groups; Kaplan-Meier survival curves and survival rates at 28 years.
Results Of those with complete data, 4387/7988 women and 4891/6967 men died over the 28 years. Compared with women in social classes I + II who had never smoked (the group with lowest mortality), the adjusted relative mortality of smoking groups ranged from 1.7 (95% confidence interval 1.3 to 2.3) to 4.2 (3.3 to 5.5). Former smokers’ mortalities were closer to those of never smokers than those of smokers. By social class (highest first), age adjusted survival rates after 28 years were 65%, 57%, 53%, and 56% for female never smokers; 41%, 42%, 33%, and 35% for female current smokers; 53%, 47%, 38%, and 36% for male never smokers; and 24%, 24%, 19%, and 18% for male current smokers. Analysis by deprivation category gave similar results.
Conclusions Among both women and men, never smokers had much better survival rates than smokers in all social positions. Smoking itself was a greater source of health inequality than social position and nullified women’s survival advantage over men. This suggests the scope for reducing health inequalities related to social position in this and similar populations is limited unless many smokers in lower social positions stop smoking.En ligne : https://doi.org/10.1136/bmj.b480 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8077 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005629 TA 3.2 GRU E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effect of viewing smoking in movies on adolescent smoking initiation : a cohort study Type de document : document électronique Auteurs : Madeline A. Dalton, Auteur ; James Sargent, Auteur ; Michael L. Beach, Auteur Editeur : Lancet Année de publication : 2003 Collection : The Lancet num. 362 Importance : p.281-285 Présentation : tab. Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] tabagisme:aspect culturel:cinéma
[TABAC] tabagisme:tabagisme actif:début du tabagisme
[TABAC] tabagisme:tabagisme actif:tabagisme adolescentIndex. décimale : TA 2.4.1 Enfants et jeunes Résumé : Background
Exposure to smoking in movies has been linked with adolescent smoking initiation in cross-sectional studies. We undertook a prospective study to ascertain whether exposure to smoking in movies predicts smoking initiation.
Method
We assessed exposure to smoking shown in movies in 3547 adolescents, aged 10–14 years, who reported in a baseline survey that they had never tried smoking. Exposure to smoking in movies was estimated for individual respondents on the basis of the number of smoking occurrences viewed in unique samples of 50 movies, which were randomly selected from a larger sample pool of popular contemporary movies. We successfully re-contacted 2603 (73%) students 13–26 months later for a follow-up interview to determine whether they had initiated smoking.
Findings
Overall, 10% (n=259) of students initiated smoking during the follow-up period. In the highest quartile of exposure to movie smoking, 17% (107) of students had initiated smoking, compared with only 3% (22) in the lowest quartile. After controlling for baseline characteristics, adolescents in the highest quartile of exposure to movie smoking were 2·71 (95% CI 1·73–4·25) times more likely to initiate smoking compared with those in the lowest quartile. The effect of exposure to movie smoking was stronger in adolescents with non-smoking parents than in those whose parent smoked. In this cohort, 52·2% (30·0–67·3) of smoking initiation can be attributed to exposure to smoking in movies.
Interpretation
Our results provide strong evidence that viewing smoking in movies promotes smoking initiation among adolescents.Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9774 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effect on smoking quit rate of telling patients their lung age : the Step2quit randomised controlled trial Type de document : texte imprimé Auteurs : Gary Parkes, Auteur ; Trisha Greenlaugh, Auteur ; Mark Griffin, Auteur ; Richard Dent, Auteur Editeur : BMJ Publishing Group Année de publication : 06/03/2008 Collection : British Medical Journal num. online Importance : 7 p. Catégories : [DIVERS] anatomie:corps humain:appareil respiratoire:poumon
[DIVERS] personne:patient
[TABAC] étude
[TABAC] étude:recherche:recherche clinique:essai clinique randomisé
[TABAC] sevrage tabagiqueIndex. décimale : TA 6.7 Facteurs influents (grossesse, adolescence…) Résumé : L'objectif de cette étude est d'évaluer l'impact de l'âge pulmonaire estimé par la spirométrie sur les patients en tant qu'incitant à arrêter de fumer. En ligne : https://www.bmj.com/content/336/7644/598 Format de la ressource électronique : HTML Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1490 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking : systematic review and meta-analysis Type de document : texte imprimé Auteurs : David Moore, Auteur ; Paul Aveyard, Auteur ; Martin Connock, Auteur Année de publication : 2009 Importance : 9 p. Note générale : BMJ 2009338:b1024 - doi:10.1136/bmj.b1024 Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotiniqueIndex. décimale : TA 6.2.3.1 Substitution nicotinique Résumé : L'objectif de cette étude est de déterminer l'efficacité et la sécurité de la méthode de substitution nicotinique en thérapie assistée dans le but d'arrêter de fumer. disponible uniquement dans la bibliothèque virtuelle Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=3075 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 002460 TA 6.2.3.1 MOO E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effectiveness of motivational interviewing in influencing smoking cessation in pregnant and postpartum disadvantaged women Type de document : document électronique Auteurs : Catherine, B. Hayes, Auteur ; Claire Collins, Auteur ; Helen O'Carroll, Auteur Editeur : Oxford University Press Année de publication : 2011 Collection : Nicotine and Tobacco Research num. 15 Importance : p. 969-977 Langues : Anglais (eng) Catégories : [DIVERS] personne:par sexe:femme:femme enceinte
[TABAC] étude
[TABAC] sevrage tabagique
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche psychologique:entretien motivationnel
[TABAC] tabagisme:risque:facteur associé:grossesse
[TABAC] tabagisme:risque:facteur associé:précaritéIndex. décimale : TA 6.2.2 Approche psychologique (y compris entretien motivationnel) Résumé : Introduction:
Systematic assessments of Motivational Interviewing (MI) in smoking behavior have been rare to date. This study aimed to determine whether an integrated approach, involving staff training in MI techniques, was sufficient to affect change in smoking status or intensity in low-income pregnant and postpartum women.
Methods:
Overall, 500 consecutive smokers were recruited at first prenatal visit to public antenatal clinics. Following staff training,500 more were recruited (intervention group). Data were recorded at 28–32 weeks gestation, after birth, at 3–4 and 7–9 months postpartum.The primary outcome measure was self-reported continued abstinence from smoking verified by urinary cotinine analysis.
Changes in smoking intensity were also measured.
Results:
There was no significant difference in the proportion of smokers in the intervention and control groups who reported stopping smoking at 28–32 weeks gestation (8.2% vs. 8.8%; p = .73), 1 week after birth (8.6% vs. 11.4%; p = .14), 3–4 months after birth (5.8% vs. 4.8%; p = .48), or 7–9 months after birth (5.2% vs. 4.0%; p = .36). Although more cases were nonsmoking at the second visit, 14.8% [95% CI = 11.8–18.5] vs. 13.1% controls [95% CI = 10.3–16.6], this was not statistically significant.
Conclusions:
MI delivered at a number of time points during pregnancy and up to 9 months postpartum failed to affect quit rates. It may have had a small effect in preventing relapse among spontaneous quitters in late pregnancy though the validity of this remains uncertain.En ligne : https://doi.org/10.1093/ntr/nts225 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9693 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effectiveness of smoking cessation therapies : a systematic review and meta-analysis Type de document : texte imprimé Auteurs : Ping Wu, Auteur ; Kumanan Wilson, Auteur ; Popey Dimoulas, Auteur Editeur : BioMed Central Année de publication : 2006 Collection : BMC Public Health num. Vol. 6 Importance : 16 p. Présentation : tab., ill. Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] étude:méta-analyse
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:bupropion
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotinique
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varéniclineIndex. décimale : TA 6.2.3 Approche pharmacologique Résumé : BACKGROUND:
Smoking remains the leading preventable cause of premature deaths. Several pharmacological interventions now exist to aid smokers in cessation. These include Nicotine Replacement Therapy [NRT], bupropion, and varenicline. We aimed to assess their relative efficacy in smoking cessation by conducting a systematic review and meta-analysis.
METHODS:
We searched 10 electronic medical databases (inception to Sept. 2006) and bibliographies of published reviews. We selected randomized controlled trials [RCTs] evaluating interventions for smoking cessation at 1 year, through chemical confirmation. Our primary endpoint was smoking cessation at 1 year. Secondary endpoints included short-term smoking cessation (approximately 3 months) and adverse events. We conducted random-effects meta-analysis and meta-regression. We compared treatment effects across interventions using head-to-head trials and when these did not exist, we calculated indirect comparisons.
RESULTS:
We identified 70 trials of NRT versus control at 1 year, Odds Ratio [OR] 1.71, 95% Confidence Interval [CI], 1.55-1.88, P =< 0.0001). This was consistent when examining all placebo-controlled trials (49 RCTs, OR 1.78, 95% CI, 1.60-1.99), NRT gum (OR 1.60, 95% CI, 1.37-1.86) or patch (OR 1.63, 95% CI, 1.41-1.89). NRT also reduced smoking at 3 months (OR 1.98, 95% CI, 1.77-2.21). Bupropion trials were superior to controls at 1 year (12 RCTs, OR1.56, 95% CI, 1.10-2.21, P = 0.01) and at 3 months (OR 2.13, 95% CI, 1.72-2.64). Two RCTs evaluated the superiority of bupropion versus NRT at 1 year (OR 1.14, 95% CI, 0.20-6.42). Varenicline was superior to placebo at 1 year (4 RCTs, OR 2.96, 95% CI, 2.12-4.12, P =< 0.0001) and also at approximately 3 months (OR 3.75, 95% CI, 2.65-5.30). Three RCTs evaluated the effectiveness of varenicline versus bupropion at 1 year (OR 1.58, 95% CI, 1.22-2.05) and at approximately 3 months (OR 1.61, 95% CI, 1.16-2.21). Using indirect comparisons, varenicline was superior to NRT when compared to placebo controls (OR 1.66, 95% CI 1.17-2.36, P = 0.004) or to all controls at 1 year (OR 1.73, 95% CI 1.22-2.45, P = 0.001). This was also the case for 3-month data. Adverse events were not systematically different across studies.
CONCLUSION:
NRT, bupropion and varenicline all provide therapeutic effects in assisting with smoking cessation. Direct and indirect comparisons identify a hierarchy of effectiveness.En ligne : https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-6-300 Format de la ressource électronique : HTML Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7965 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effectiveness of the electronic cigarette : an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints Type de document : texte imprimé Auteurs : Karolien Adriaens, Auteur ; Dinska Van Gucht, Auteur ; Paul Declerck, Auteur Editeur : Bâle [Suisse] : MDPI AG (Molecular Diversity Preservation International) Année de publication : novembre 2014 Collection : International Journal of Environmental Research and Public Health, ISSN 1660-4601 num. 11:11 Importance : p.11220-11248 Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe occidentale:Belgique
[TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] étude
[TABAC] sevrage tabagique
[TABAC] tabagisme:aspect psychologique:comportement:addictionIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : Les cigarettes électroniques offrent aux fumeurs un moyen réaliste d’abandonner leur dépendance au tabac. Dans une nouvelle étude publiée dans la Revue internationale de la recherche environnementale et de la santé publique , des scientifiques de la KU Leuven ont déclaré que les cigarettes électroniques réduisaient avec succès l'envie de fumer des cigarettes de tabac, avec seulement des effets secondaires minimes. En ligne : https://doi.org/10.3390/ijerph111111220 Format de la ressource électronique : PDF, HTML Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8946 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 006972 TA 6.2.3.2 ECI Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effectiveness of varenicline as an aid to smoking cessation : results of an inter-european observational study Type de document : texte imprimé Auteurs : Hedwig Boudrez, Auteur ; Christina Gratziou, Auteur ; Michael Messig, Auteur Année de publication : 2010 Importance : 1 p. Présentation : tab., graph. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe
[TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varéniclineIndex. décimale : TA 6.2.3.2 Autres produits Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8439 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005036 TA 6.2.3.2 BOU E Affiche Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effects of cannabis on lung function : a population-based cohort study Type de document : texte imprimé Auteurs : R.J. Hancox, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2010 Collection : European Respiratory Journal num. 35 (1) Importance : p. 42-47 Langues : Anglais (eng) Catégories : [DIVERS] anatomie:corps humain:appareil respiratoire
[TABAC] étude
[TABAC] tabagisme:risque:facteur associé:drogue:cannabis
[TABAC] tabagisme:tabagisme actifIndex. décimale : TA 1.1.5 Cannabis Résumé : The effects of cannabis on lung function remain unclear and may be different from those of tobacco. We compared the associations between use of these substances and lung function in a population-based cohort (n = 1,037). Cannabis and tobacco use were reported at ages 18, 21, 26 and 32 yrs. Spirometry, plethysmography and carbon monoxide transfer factor were measured at 32 yrs. Associations between lung function and exposure to each substance were adjusted for exposure to the other substance. Cumulative cannabis use was associated with higher forced vital capacity, total lung capacity, functional residual capacity and residual volume. Cannabis was also associated with higher airway resistance but not with forced expiratory volume in 1 s, forced expiratory ratio or transfer factor. These findings were similar among those who did not smoke tobacco. In contrast, tobacco use was associated with lower forced expiratory volume in 1 s, lower forced expiratory ratio, lower transfer factor and higher static lung volumes, but not with airway resistance. Cannabis appears to have different effects on lung function from those of tobacco. Cannabis use was associated with higher lung volumes, suggesting hyperinflation and increased large-airways resistance, but there was little evidence for airflow obstruction or impairment of gas transfer. En ligne : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805041/ Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2706 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effects of cigarette smoking cessation on breastfeeding duration Type de document : document électronique Auteurs : Tara, M. Higgins, Auteur ; Stephen, T. Higgins, Auteur ; Sarah, H. Heil, Auteur Editeur : Oxford University Press Année de publication : 2010 Collection : Nicotine and Tobacco Research num. 12:5 Importance : p. 483–488 Langues : Anglais (eng) Catégories : [DIVERS] personne:par sexe:femme:femme enceinte
[TABAC] étude
[TABAC] prévention:santé:promotion de la santé:alimentation:allaitement
[TABAC] sevrage tabagiqueIndex. décimale : TA 3.2.2.7 Grossesse et fœtus Résumé : Introduction:
The purpose of this study was to use data from controlled trials to examine whether smoking cessation increases breastfeeding duration. Correlational studies have confirmedassociations between smoking status and breastfeeding duration, but whether smoking cessation increases breastfeeding duration has not been established.
Methods:
Participants ( N = 158) were smokers at the start of prenatal care who participated in controlled trials on smoking cessation. Women were assigned to either an incentive-based intervention wherein they earned vouchers exchangeable for retail items by abstaining from smoking or a control condition where they received comparable vouchers independent of smoking status. Treatments were provided antepartum through 12-week postpartum. Maternal reports of breastfeeding collected at 2-,
4-, 8-, 12-, and 24-week postpartum were compared between treatment conditions. Whether women were exclusively breastfeeding was not investigated.
Results:
The incentive-based treatment signifi cantly increased breastfeeding duration compared with rates observed among women receiving the control treatment, with signifi cant differences between treatment conditions observed at 8-week (41% vs. 26%; odds ratio [ OR ] = 2.7, 95% CI = 1.3– 5.6, p = .01) and 12-week
(35% vs. 17%; OR = 3.4, 95% CI = 1.5– 7.6, p = .002) postpartum. No significant treatment effects on breastfeeding were observed at other assessments. Changes in smoking status mediated the effects of treatment condition on breastfeeding duration.
Conclusions:
These results provide evidence from controlled studies that smoking cessation increases breastfeeding duration, which, to our knowledge, has not been previously reportedEn ligne : https://doi.org/10.1093%2Fntr%2Fntq031 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9576 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effects of a generalised ban on smoking in bars and restaurants, Italy Type de document : texte imprimé Auteurs : N. Binkin, Auteur Editeur : International Union Against Tuberculosis and Lung Disease (IUATLD) Année de publication : 2007 Collection : International Journal of Tuberculosis and Lung Disease num. 11 (5) Importance : p. 522-257 Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe méridionale:Italie
[TABAC] étude
[TABAC] législation
[TABAC] législation:législation antitabac:interdiction de fumer
[TABAC] législation:milieu réglementé:horeca
[TABAC] tabagisme:tabagisme passifIndex. décimale : TA 9.2 Législation d’autres pays Résumé : En janvier 2005, l'Italie a mis en oeuvre une loi interdisant de fumer dans tous les lieux publics fermés. L'objectif de cette étude est de documenter les obstacles perçus ainsi que les effets de la loi et observer les comportements tabagiques des clients dans les bars et les restaurants. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2739 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 001485 TA 9.2 BIN E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effects of varenicline on smoking cessation in adults with stably treated current or past major depression : a randomized trial Type de document : texte imprimé Auteurs : Robert M. Anthenelli, Auteur ; Chad Morris, Auteur ; Tanya S. Ramey, Auteur Editeur : American College of Physicians Année de publication : 2013 Collection : Annals of internal medicine, ISSN 0003-4819 num. vol 159, n.6 Importance : p. 390-400 Présentation : ill., tab. Langues : Anglais (eng) Catégories : [TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varénicline
[TABAC] tabagisme:effet du tabac:effet psychiatrique:dépressionIndex. décimale : TA 6.2.3.1.4 Autres substituts nicotiniques Résumé : Background: Depression is overrepresented in smokers.
Objective: To evaluate smoking abstinence and changes in mood and anxiety levels in smokers with depression treated with varenicline versus placebo.
Design: Phase 4, multicenter, parallel, 1:1 allocation, double-blind, randomization trial. Randomization, stratified by antidepressant use and depression score at baseline, was blocked in sizes of 4. (ClinicalTrials.gov: NCT01078298)
Setting: 38 centers in 8 countries.
Participants: 525 adult smokers with stably treated current or past major depression and no recent cardiovascular events.
Intervention: Varenicline, 1 mg twice daily, or placebo for 12 weeks, with 40-week nontreatment follow-up.
Measurements: Primary outcome was carbon monoxide–confirmed continuous abstinence rate (CAR) for weeks 9 to 12. Other outcomes included CARs assessed during nontreatment follow-up and ratings of mood, anxiety, and suicidal ideation or behavior.
Results: 68.4% versus 66.5% of the varenicline and placebo groups, respectively, completed the study. Varenicline-treated participants had higher CARs versus placebo at weeks 9 to 12 (35.9% vs. 15.6%; odds ratio [OR], 3.35 [95% CI, 2.16 to 5.21]; P < 0.001), 9 to 24 (25.0% vs. 12.3%; OR, 2.53 [CI, 1.56 to 4.10]; P < 0.001), and 9 to 52 (20.3% vs. 10.4%; OR, 2.36 [CI, 1.40 to 3.98]; P = 0.001). There were no clinically relevant differences between groups in suicidal ideation or behavior and no overall worsening of depression or anxiety in either group. The most frequent adverse event was nausea (varenicline, 27.0%; placebo, 10.4%). Two varenicline-group participants died during the nontreatment phase.
Limitations: Some data were missing, and power to detect differences between groups was low in rare events. Smokers with untreated depression, with co-occurring psychiatric conditions, or receiving mood stabilizers and antipsychotics were not included.
Conclusion: Varenicline increased smoking cessation in smokers with stably treated current or past depression without exacerbating depression or anxiety.En ligne : https://annals.org/aim/fullarticle/1738494/effects-varenicline-smoking-cessation [...] Format de la ressource électronique : HTML Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7935 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Effects of varenicline on smoking cessation in mild-to moderate COPD : a randomized controlled trial Type de document : texte imprimé Auteurs : D.P. Tashkin, Auteur ; Stephen I Rennard, Auteur ; J. Taylor Hays, Auteur Editeur : American College of Chest Physicians Année de publication : 2010 Collection : Chest, ISSN 0012-3692 Importance : 30 p. Présentation : tab. Langues : Français (fre) Catégories : [TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varéniclineIndex. décimale : TA 6.2.3.1.4 Autres substituts nicotiniques Résumé : BACKGROUND:
Smoking is the most important risk factor for COPD and accelerates its progression. Despite the health implications, a large proportion of patients with COPD continue to smoke, so finding effective smoking cessation interventions for this population is paramount. To our knowledge, this is the first randomized clinical trial to compare the efficacy and safety of varenicline tartrate vs placebo in smokers with mild to moderate COPD.
METHODS:
In a 27-center, double-blind, multinational study, 504 patients with mild to moderate COPD (postbronchodilator FEV1/FVC, <70%; FEV1 percent predicted normal value, ≥50%) and without known psychiatric disturbances were randomized to receive varenicline (n=250) or placebo (n=254) for 12 weeks, with a 40-week nontreatment follow-up. The primary end point was carbon monoxide-confirmed continuous abstinence rate (CAR) for weeks 9 to 12. A secondary end point was CAR for weeks 9 to 52.
RESULTS:
CAR for weeks 9 to 12 was significantly higher for patients in the varenicline group (42.3%) than for those in the placebo group (8.8%) (OR, 8.40; 95% CI, 4.99-14.14; P<.0001). CAR in the patients treated with varenicline remained significantly higher than in those treated with placebo through weeks 9 to 52 (18.6% vs 5.6%) (OR, 4.04; 95% CI, 2.13-7.67; P<.0001). Nausea, abnormal dreams, upper-respiratory tract infection, and insomnia were the most commonly reported adverse events (AEs) for patients in the varenicline group. Serious AEs were infrequent in both treatment groups. Two patients in the varenicline group and one patient in the placebo group died during the study. Reports of psychiatric AEs were similar for both treatment groups.
CONCLUSIONS:
Varenicline was more efficacious than placebo for smoking cessation in patients with mild to moderate COPD and demonstrated a safety profile consistent with that observed in previous trials.Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7933 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005474 TA 6.2.3.1.4 TAS E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
